home
PAH
preclinical development
directors and officers


Corporate Head Office

Suite 301, 1875 Maurice-Gauvin Street,
Laval, QC, H7S 2M5

Phone: 514-842 0071

If you want to learn more about the SAPPHIRE trial and the Sepsis cell therapy, contact Northern Therapeutics at +1 343 291 1196 / email: Lmccurdy@northernther.com.